NCT04578938View on ClinicalTrials.gov

Ketamine + Cognitive Training for Suicidality in the Medical Setting

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

March 2, 2026

Study Completion Date

March 2, 2026

Conditions
Suicide, Attempted
Interventions
DRUG

Intravenous ketamine

Single subanesthetic infusion of ketamine (0.5mg/kg)

BEHAVIORAL

Cognitive training

8 sessions of computer-based cognitive training

BEHAVIORAL

Sham Training

8 sessions of computer-based sham training

Trial Locations (1)

15213

University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Rebecca Price

OTHER